Status:
COMPLETED
Clinical Hypnosis and Home Blood Pressure Monitoring in Children With Neurofibromatosis Type 1
Lead Sponsor:
Murdoch Childrens Research Institute
Conditions:
Hypertension
Neurofibromatosis 1
Eligibility:
All Genders
5-18 years
Phase:
NA
Brief Summary
This study has two primary objectives. The first is to determine if it is feasible and reliable for children and families with a diagnosis of Neurofibromatosis Type 1 (NF1) to use of blood pressure (B...
Detailed Description
Neurofibromatosis Type 1 (NF1) is a rare autosomal dominate genetic disorder that affects an estimated that 1 in 2500 people or 10000 Australians. NF1 affects multiple systems throughout the body. The...
Eligibility Criteria
Inclusion
- Is between the ages of 5 and 18 years old at enrolment.
- Has a diagnosis of neurofibromatosis type 1(NF1), confirmed by a physician, and usually attends the NF clinic at The Royal Children's Hospital, Melbourne, Australia (RCH). Including children with known kidney and cardiac disease.
- Primary residence and residential postal address in Victoria.
- The child can sit quietly for 10-15 minutes at home to complete a blood pressure assessment.
- Provide a signed and dated participant and/or parent guardian information and consent form and or has a legally acceptable representative capable of understanding the informed consent document and providing consent on the participant's behalf.
- For inclusive diverse study group, Parent/caregiver who require an interpreter can be enrolled in this study. Only inhouse interpreter services able to be included,
Exclusion
- Has clinically significant cognitive impairment or attention disorder preventing ability to sit in a chair for 15 minutes
- Has confirmed hypertension on previous testing
- Parent/caregiver who require an interpreter and cannot upload BP and Heart rate (HR) values online independently will be excluded from the study.
- Parent/caregiver requiring an interpreter, but the interpreter not present within the face-to-face appointment eg, phone interpreter services.
Key Trial Info
Start Date :
May 25 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 24 2023
Estimated Enrollment :
54 Patients enrolled
Trial Details
Trial ID
NCT05196854
Start Date
May 25 2022
End Date
April 24 2023
Last Update
February 24 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Murdoch Children's Research Institute
Parkville, Victoria, Australia, 3050